Published in Hepatitis Weekly, December 9th, 2002
Patients who undergo surgery for HCV-related hepatocellular carcinoma (HCC) typically undergo a battery of tests at follow-up to check for recurrent liver dysfunction, or hepatitis. One of those tests is for alanine aminotransferase (ALT), an enzyme associated liver disorder.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.